glp-1 obesity drug news today september 15 2025 anti-obesity drugs lead to substantial weight loss in the “real world” Oral GLP-1 Pill Delivers Injection-Like

If side effects occur at a higher dose, the medication dose may be reduced to the previously tolerated dose

Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial

Back Heinrich, G, Gros, P, Lund, PK, et al (1984) 'Pre-Proglucagon Messenger Ribonucleic Acid: Nucleotide and Encoded Amino Acid Sequences of the rat pancreatic complementary deoxyribonucleic acid', Endocrinology , 115/6, 2176-81

Gut microbial dysbiosis in the irritable bowel syndrome: A systematic review and Meta-Analysis of Case-Control studies

serves on advisory boards of Sanofi Aventis and Merck Sharp & Dohme (all honoraria paid to employer)